These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25444864)

  • 1. Effect of insulin deficiency on the rewarding properties of methamphetamine in streptozotocin-induced diabetic rats.
    Bayat AH; Haghparast A
    Pharmacol Biochem Behav; 2015 Jan; 128():8-13. PubMed ID: 25444864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular microinjection of the 5-HT
    Shahidi S; Sadeghian R; Komaki A; Asl SS
    Pharmacol Biochem Behav; 2018 Oct; 173():27-35. PubMed ID: 30077744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
    Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
    Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of vesicular glutamate transporters contributes to attenuate methamphetamine-induced conditioned place preference in rats.
    He Z; Chen Y; Dong H; Su R; Gong Z; Yan L
    Behav Brain Res; 2014 Jul; 267():1-5. PubMed ID: 24613241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats.
    Zakharova E; Leoni G; Kichko I; Izenwasser S
    Behav Brain Res; 2009 Mar; 198(1):45-50. PubMed ID: 18996417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptozotocin-induced diabetes affects the development and maintenance of morphine reward in rats.
    Samandari R; Chizari A; Hassanpour R; Mousavi Z; Haghparast A
    Neurosci Lett; 2013 May; 543():90-4. PubMed ID: 23545208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
    Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
    J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned place preference following concurrent treatment with 3, 4-methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats.
    Risca HI; Zuarth-Gonzalez JD; Baker LE
    Pharmacol Biochem Behav; 2020 Nov; 198():173032. PubMed ID: 32888971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
    Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
    Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinstatement of methamphetamine conditioned place preference in nicotine-sensitized rats.
    Berry JN; Neugebauer NM; Bardo MT
    Behav Brain Res; 2012 Dec; 235(2):158-65. PubMed ID: 22884606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.
    Riddle JL; Rokosik SL; Napier TC
    Behav Brain Res; 2012 Jul; 233(1):15-23. PubMed ID: 22727039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of mitogen-stimulated p70-S6 kinase in the development of sensitization to the methamphetamine-induced rewarding effect in rats.
    Narita M; Akai H; Kita T; Nagumo Y; Narita M; Sunagawa N; Hara C; Hasebe K; Nagase H; Suzuki T
    Neuroscience; 2005; 132(3):553-60. PubMed ID: 15837117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.
    Clough SJ; Hutchinson AJ; Hudson RL; Dubocovich ML
    Physiol Behav; 2014 Jun; 132():79-86. PubMed ID: 24813704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin blocks methamphetamine-induced sensitization and conditioned place preference via inhibition of α₂/δ-1 subunits of the voltage-gated calcium channels.
    Kurokawa K; Shibasaki M; Mizuno K; Ohkuma S
    Neuroscience; 2011 Mar; 176():328-35. PubMed ID: 21182903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
    Itzhak Y; Martin JL; Ali SF
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice.
    Fujita Y; Kunitachi S; Iyo M; Hashimoto K
    Pharmacol Biochem Behav; 2012 Apr; 101(2):303-6. PubMed ID: 22260872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
    Sun L; Song R; Chen Y; Yang RF; Wu N; Su RB; Li J
    Acta Pharmacol Sin; 2016 Feb; 37(2):157-65. PubMed ID: 26687935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circadian gene, Per2, influences methamphetamine sensitization and reward through the dopaminergic system in the striatum of mice.
    Kim M; Custodio RJ; Botanas CJ; de la Peña JB; Sayson LV; Abiero A; Ryoo ZY; Cheong JH; Kim HJ
    Addict Biol; 2019 Sep; 24(5):946-957. PubMed ID: 30091820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Roles of Intra-accumbal Orexin Receptors in Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference in the Rats.
    Khosrowabadi E; Karimi-Haghighi S; Jamali S; Haghparast A
    Neurochem Res; 2020 Sep; 45(9):2230-2241. PubMed ID: 32643036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a 5-HT
    Shahidi S; Komaki A; Sadeghian R; Soleimani Asl S
    Brain Res; 2018 Nov; 1698():151-160. PubMed ID: 30076792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.